202 related articles for article (PubMed ID: 28151897)
1. Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.
Kim J; Cho SG; Kang SR; Kwon SY; Cho DH; Cho JS; Song HC
Medicine (Baltimore); 2017 Feb; 96(5):e6004. PubMed ID: 28151897
[TBL] [Abstract][Full Text] [Related]
2. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.
Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC
PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831
[TBL] [Abstract][Full Text] [Related]
4. Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration.
Lee H; Paeng JC; Choi H; Cho SW; Park YJ; Park DJ; Lee YA; Chung JK; Kang KW; Cheon GJ
PLoS One; 2021; 16(9):e0256727. PubMed ID: 34492048
[TBL] [Abstract][Full Text] [Related]
5. Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.
Tuttle RM; Lopez N; Leboeuf R; Minkowitz SM; Grewal R; Brokhin M; Omry G; Larson S
Thyroid; 2010 Mar; 20(3):257-63. PubMed ID: 20187781
[TBL] [Abstract][Full Text] [Related]
6. Effect of preparation method for radioactive iodine therapy on serum electrolytes.
Takata N; Miyagawa M; Okada T; Kawaguchi N; Fujimoto Y; Kouchi Y; Tsuruoka S; Uwatsu K; Kido T
Jpn J Radiol; 2023 Nov; 41(11):1247-1254. PubMed ID: 37184818
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer.
Vannucci L; Parenti G; Simontacchi G; Rastrelli G; Giuliani C; Ognibene A; Peri A
J Endocrinol Invest; 2017 Jan; 40(1):49-54. PubMed ID: 27507082
[TBL] [Abstract][Full Text] [Related]
8. Low iodine diet in differentiated thyroid cancer: a review.
Li JH; He ZH; Bansal V; Hennessey JV
Clin Endocrinol (Oxf); 2016 Jan; 84(1):3-12. PubMed ID: 26118628
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod).
Leenhardt L; Leboulleux S; Bournaud C; Zerdoud S; Schvartz C; Ciappuccini R; Kelly A; Morel O; Dygai-Cochet I; Rusu D; Chougnet CN; Lion G; Eberlé-Pouzeratte MC; Catargi B; Kabir-Ahmadi M; Le Peillet Feuillet E; Taïeb D
J Clin Endocrinol Metab; 2019 Apr; 104(4):1020-1028. PubMed ID: 30398518
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma: The First Report in Nonwestern Countries.
Joung JY; Choi JH; Cho YY; Kim NK; Sohn SY; Kim SW; Chung JH
Am J Clin Oncol; 2016 Aug; 39(4):374-8. PubMed ID: 24732812
[TBL] [Abstract][Full Text] [Related]
11. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Serhal DI; Nasrallah MP; Arafah BM
J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.
Hugo J; Robenshtok E; Grewal R; Larson S; Tuttle RM
Thyroid; 2012 Oct; 22(10):1007-15. PubMed ID: 22873801
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review.
Sunavala-Dossabhoy G; Petti S
Oral Oncol; 2023 Jan; 136():106280. PubMed ID: 36525783
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin.
Cho YY; Kim SK; Jung JH; Hahm JR; Kim TH; Chung JH; Kim SW
Endocrine; 2019 May; 64(2):293-298. PubMed ID: 30471053
[TBL] [Abstract][Full Text] [Related]
15. Hyperkalemia develops in some thyroidectomized patients undergoing thyroid hormone withdrawal in preparation for radioactive iodine ablation for thyroid carcinoma.
Horie I; Ando T; Imaizumi M; Usa T; Kawakami A
Endocr Pract; 2015 May; 21(5):488-94. PubMed ID: 25667379
[TBL] [Abstract][Full Text] [Related]
16. Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation.
Molinaro E; Leboeuf R; Shue B; Martorella AJ; Fleisher M; Larson S; Tuttle RM
Thyroid; 2009 Oct; 19(10):1035-41. PubMed ID: 19772430
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Mizowaki T
Ann Nucl Med; 2019 Jul; 33(7):495-501. PubMed ID: 30955202
[TBL] [Abstract][Full Text] [Related]
18. Low-Iodine Diet of 4 Days Is Sufficient Preparation for 131I Therapy in Differentiated Thyroid Cancer Patients.
Dekker BL; Links MH; Muller Kobold AC; Swart-Busscher LG; Kars M; Bons JAP; Brouwers AH; Links TP; van der Horst-Schrivers ANA
J Clin Endocrinol Metab; 2022 Jan; 107(2):e604-e611. PubMed ID: 34534327
[TBL] [Abstract][Full Text] [Related]
19. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
Abe K; Ishizaki U; Ono T; Horiuchi K; Kanaya K; Sakai S; Okamoto T
Ann Nucl Med; 2020 Feb; 34(2):144-151. PubMed ID: 31834567
[TBL] [Abstract][Full Text] [Related]
20. Radioactive iodine scanning is not beneficial but its use persists for euthyroid patients.
Panneerselvan R; Schneider DF; Sippel RS; Chen H
J Surg Res; 2013 Sep; 184(1):269-73. PubMed ID: 23623585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]